Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $2 | $3 | $2 |
| Gross Profit | $0 | -$2 | -$3 | -$2 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $528 | $497 |
| G&A Expenses | $0 | $376 | $1,221 | $1,553 |
| SG&A Expenses | $2 | $1,221 | $1,221 | $1,553 |
| Sales & Mktg Exp. | $0 | $281 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $1,221 | $1,752 | $2,051 |
| Operating Income | -$2 | -$1,221 | -$1,750 | -$1,972 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$179 | -$2 | -$79 |
| Pre-Tax Income | -$2 | -$1,399 | -$1,754 | -$2,051 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2 | -$1,399 | -$1,754 | -$2,051 |
| % Margin | – | – | – | – |
| EPS | -0.012 | -0.011 | -0.016 | -0.022 |
| % Growth | -15.9% | 34.4% | 24.9% | – |
| EPS Diluted | -0.012 | -0.011 | -0.016 | -0.022 |
| Weighted Avg Shares Out | 138 | 130,510 | 107,826 | 94,681 |
| Weighted Avg Shares Out Dil | 138 | 130,504 | 107,826 | 94,678 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $3 |
| Depreciation & Amortization | $0 | $2 | $3 | $2 |
| EBITDA | -$2 | -$1,221 | -$1,751 | -$2,043 |
| % Margin | – | – | – | – |